Cleveland Paul B 4
4 · ALDER BIOPHARMACEUTICALS INC · Filed Mar 27, 2018
Insider Transaction Report
Form 4
Cleveland Paul B
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-03-26+100,000→ 100,000 totalExercise: $11.95Exp: 2028-03-25→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]If the Reporting Person remains continuously employed with the Issuer through the earlier to occur of (i) September 15, 2018 and (ii) the date that a new CEO begins employment with the Issuer (such earlier date, the "Earn Date"), 100% of the shares subject to the option will immediately vest on the Earn Date.